LNG exporter Venture Global slashes IPO price range
Ascentage Pharma raises $126m in 1st biotech IPO of 2025
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results